Literature DB >> 1753122

Moraxella atlantae bacteraemia in a patient with systemic lupus erythematosis.

A L Buchman1, M J Pickett.   

Abstract

We describe the first reported case of human infection caused by Moraxella atlantae (formerly known as CDC group M-3) and its successful treatment with intravenous cefuroxime. The isolation and identification of this species, as well as the pathogenesis of the infection, are discussed. It is recommended that isolates of Moraxella species be speciated so that the epidemiological characteristics and pathogenesis of the infections caused by the various species may be understood more completely.

Entities:  

Mesh：

Year:  1991        PMID： 1753122     DOI： 10.1016/0163-4453(91)92335-3

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


  4 in total

1.  Bacteremia due to Moraxella atlantae in a cancer patient.

Authors:  Thierry De Baere; An Muylaert; Els Everaert; Georges Wauters; Geert Claeys; Gerda Verschraegen; Mario Vaneechoutte
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

2.  [Isolation of Moraxella atlantae on the valve of a patient with native infective endocarditis].

Authors:  C Carbonell-Muñoz; S Zhilina; A Barbosa-Ventura; S Hernández-Egido; I García-García; A J Chamorro-Fernández; M Marcos-Martín
Journal:  Rev Esp Quimioter       Date:  2018-10-30       Impact factor: 1.553

3.  Moraxella atlantae keratitis presenting with an infectious ring ulcer.

Authors:  Alexander Barash; Timothy Y Chou
Journal:  Am J Ophthalmol Case Rep       Date:  2017-06-12

4.  Identification of Gram negative non-fermentative bacteria: How hard can it be?

Authors:  Toni Whistler; Ornuma Sangwichian; Possawat Jorakate; Pongpun Sawatwong; Uraiwan Surin; Barameht Piralam; Somsak Thamthitiwat; Chidchanok Promkong; Leonard Peruski
Journal:  PLoS Negl Trop Dis       Date:  2019-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.